Clinico-mycological Profile of Dermatophytic Infections at a Tertiary Care Hospital in North India

Kucheria, Monika

doi:10.21276/ijchmr.2016.2.2.03

Cited by 11 publications

(1 citation statement)

References 4 publications

(6 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data for community level prevalence of this condition is not available, but various hospital-based studies present disease burden in the range of 36.6%–78.4%. [ 1 2 3 4 5 ] Considering that these data are from highly specialized skin care facilities, these numbers represent just the tip of the iceberg; and as it is common community practice to seek advice from general practitioners, quacks, and even pharmaceutical stores for dermatophytosis, this study was undertaken to analyze disease impact on quality of life (QoL) of patient and finance of the family. A striking feature of this epidemic is its chronicity and recurrence of dermatophytosis.…”

Section: Introductionmentioning

confidence: 99%

Psychosocial and financial impact of disease among patients of dermatophytosis, a questionnaire-based observational study

Patel

Padhiyar

Patel

et al. 2020

Indian Dermatol Online J

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Psychosocial and financial impact of disease among patients of dermatophytosis, a questionnaire-based observational study

Patel

Padhiyar

Patel

et al. 2020

Indian Dermatol Online J

View full text Add to dashboard Cite

Milestones in Medical Mycology in India

Gugnani

2021

Progress in Mycology

View full text Add to dashboard Cite

Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India)

et al. 2018

View full text Add to dashboard Cite

BackgroundDermatophytosis management has become an important public health issue, with a large void in research in the area of disease pathophysiology and management. Current treatment recommendations appear to lose their relevance in the current clinical scenario. The objective of the current consensus was to provide an experience-driven approach regarding the diagnosis and management of tinea corporis, cruris and pedis.MethodsEleven experts in the field of clinical dermatology and mycology participated in the modified Delphi process consisting of two workshops and five rounds of questionnaires, elaborating definitions, diagnosis and management. Panel members were asked to mark “agree” or “disagree” beside each statement, and provide comments. More than 75% of concordance in response was set to reach the consensus.ResultKOH mount microscopy was recommended as a point of care testing. Fungal culture was recommended in chronic, recurrent, relapse, recalcitrant and multisite tinea cases. Topical monotherapy was recommended for naïve tinea cruris and corporis (localised) cases, while a combination of systemic and topical antifungals was recommended for naïve and recalcitrant tinea pedis, extensive lesions of corporis and recalcitrant cases of cruris and corporis. Because of the anti-inflammatory, antibacterial and broad spectrum activity, topical azoles should be preferred. Terbinafine and itraconazole should be the preferred systemic drugs. Minimum duration of treatment should be 2–4 weeks in naïve cases and > 4 weeks in recalcitrant cases. Topical corticosteroid use in the clinical practice of tinea management was strongly discouraged.ConclusionThis consensus guideline will help to standardise care, provide guidance on the management, and assist in clinical decision-making for healthcare professionals.

show abstract

Clinico-mycological Profile of Dermatophytic Infections at a Tertiary Care Hospital in North India

Abstract: Corresponding author:

Cited by 11 publications

References 4 publications

Psychosocial and financial impact of disease among patients of dermatophytosis, a questionnaire-based observational study

Psychosocial and financial impact of disease among patients of dermatophytosis, a questionnaire-based observational study

Milestones in Medical Mycology in India

Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India)

Contact Info

Product

Resources

About